RussiaТs Nanolek says revenue triples to 2.6 bln rbl in 2017 - News Archive - PRIME Business News Agency - All News Politics Economy Business Wire Financial Wire Oil Gas Chemical Industry Power Industry Metals Mining Pulp Paper Agro Commodities Transport Automobile Construction Real Estate Telecommunications Engineering Hi-Tech Consumer Goods Retail Calendar Our Features Interviews Opinions Press Releases

RussiaТs Nanolek says revenue triples to 2.6 bln rbl in 2017

MOSCOW, Feb 13 (PRIME) -- The revenue of Russian biopharmaceutical company Nanolek, a subsidiary of state nanotechnology company Rusnano, tripled on the year to 2.6 billion rubles in 2017, the company said in a statement on Tuesday without providing accounting standards.

The companyТs production at the plant in the Kirov Region rose 20% to 8.1 million packs last year.

УThe companyТs plans for 2018 include strengthening of positions in directions that we chose Ц vaccines, medicines for treatment of orphan diseases, and retrovirus therapy. The company continues investment in portfolio development, in clinical tests, and in registration of new medicines. The combined investment portfolio will exceed 350 million rubles in 2018,Ф the company said quoting its President Vladimir Khristenko.

(58.0171 rubles Ц U.S. $1)


13.02.2018 18:05
Share |
To report an error select text and press Ctrl+Enter
Central Bank Official Rate
1W 1M 1Y
EUR 70.6997 -0.1527 22 nov
USD 63.8430 -0.1783 22 nov
Stock Market Indices
1D 1W 1M 1Y
rtsi 1452.58 +0.29 17:27 21 nov
micex 2939.60 +0.11 17:27 21 nov
Stock Quotes in RUR
1D 1W 1M 1Y
gazp 256.01 +3.23 17:09 21 nov
lkoh 6076.00 -0.14 17:09 21 nov
rosn 453.75 +0.75 17:09 21 nov
sber 236.70 -0.45 17:09 21 nov
MICEX Ruble Trading
1D 1W 1M 1Y
EURTD 70.6550 -0.0850 14:59 21 nov
USDTD 63.7200 -0.2300 17:08 21 nov